The use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors

Richard Feelders, Lynnette K. Nieman, André Ulmann, Compositions for and methods of treatment and enhanced detection of non-pituitary tumors ,(2012)

Idit Sagiv-Barfi, Holbrook E. K. Kohrt, Ronald Levy, Betty Chang, Patrick Ng, Treatment using Bruton's tyrosine kinase inhibitors and immunotherapy ,(2014)

Benoit Gourdet, Iain Walters, Hazel Hunt, Octahydro fused azadecalin glucocorticoid receptor modulators ,(2014)

Tony Johnson, Nicholas Ray, Iain Walters, Hazel Hunt, Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators ,(2013)

Vafa Shahabi, Rui-Ru Ji, Anti-tumor antibodies as predictive or prognostic biomarkers of efficacy and survival in ipilimumab-treated patients ,(2013)

Erard Gilles, Methods and systems for identifying and treating anti-progestin sensitive tumors ,(2012)

Suzanne D. Conzen, Masha Kocherginsky, Deng Pan, Methods and compositions related to glucocorticoid receptor antagonists and breast cancer ,(2013)

Robin D Clark, Nicholas C Ray, Paul Blaney, Peter H Crackett, Christopher Hurley, Karen Williams, Hazel J Dyke, David E Clark, Peter M Lockey, Rene Devos, Melanie Wong, Anne White, Joseph K Belanoff, None, 2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists. Bioorganic & Medicinal Chemistry Letters. ,vol. 17, pp. 5704- 5708 ,(2007) , 10.1016/J.BMCL.2007.07.055

Maxwell N. Skor, Erin L. Wonder, Masha Kocherginsky, Anju Goyal, Ben A. Hall, Yi Cai, Suzanne D. Conzen, Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clinical Cancer Research. ,vol. 19, pp. 6163- 6172 ,(2013) , 10.1158/1078-0432.CCR-12-3826

Levi Garraway, Marios Giannakis, Kynurenine Pathway Biomarkers Predictive of Anti-Immune Checkpoint Inhibitor Response ,(2014)